These differences matter because access challenges, such as refill difficulty and medication switching, show up across every care pathway, suggesting that no single model has solved the problem of continuity
This inhibits the activity of the Xc-system, blocking cystine input, and ultimately leading to the occurrence of cellular ferroptosis [40]
Multiple European countriesGermany, Sweden, France, Switzerland, the United Kingdom and the Netherlands--offer dCBT-I treatment programs backed by at least one randomized controlled trial
With healthy lifestyle changes and effective treatment, many people may be able to prevent advanced-stage CKD
The study's authors said they did not conduct any statistical analysis across all of the studies because of differences between study designs